Abstract
We have recently identified BMS-345541 (1) as a highly selective and potent inhibitor of IKK-2 (IC50 = 0.30 microM), which however was considerably less potent against IKK-1 (IC50 = 4.0 microM). In order to further explore the SAR around the imidazoquinoxaline tricyclic structure of 1, we prepared a series of tetracyclic analogues (7, 13, and 18). The synthesis and biological activities of these potent IKK inhibitors are described.
MeSH terms
-
Benzimidazoles / chemical synthesis
-
Benzimidazoles / pharmacology
-
Cell Line
-
Heterocyclic Compounds, 4 or More Rings / chemical synthesis*
-
Heterocyclic Compounds, 4 or More Rings / pharmacology*
-
Humans
-
I-kappa B Kinase / antagonists & inhibitors*
-
Inhibitory Concentration 50
-
Quinazolines / chemical synthesis
-
Quinazolines / pharmacology
-
Quinolines / chemical synthesis
-
Quinolines / pharmacology
-
Quinoxalines / chemical synthesis
-
Quinoxalines / pharmacology
-
Structure-Activity Relationship
-
Substrate Specificity
Substances
-
Benzimidazoles
-
Heterocyclic Compounds, 4 or More Rings
-
Quinazolines
-
Quinolines
-
Quinoxalines
-
I-kappa B Kinase